C4 Therapeutics Inc. (CCCC) Statistics & Valuation Metrics - Stocknear

C4 Therapeutics Inc.

NASDAQ: CCCC · Real-Time Price · USD
2.22
0.03 (1.37%)
At close: Sep 26, 2025, 1:07 PM

C4 Therapeutics Statistics

Share Statistics

C4 Therapeutics has 71.17M shares outstanding. The number of shares has increased by 2.41% in one year.

71.17M
2.41%
0.02%
92.4%
59.99M
848
0.05%

Short Selling Information

The latest short interest is 3.78M, so 5.33% of the outstanding shares have been sold short.

3.78M
5.33%
5.75%
3.29

Valuation Ratios

The PE ratio is -2.37 and the forward PE ratio is -1.38. C4 Therapeutics's PEG ratio is 0.06.

-2.37
-1.38
7.02
7.7
1.16
-3.82
0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for C4 Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.71, with a Debt / Equity ratio of 0.3.

5.71
5.71
0.3
-0.64
-1.01
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$323.49K
$-957.42K
110
0.1
n/a

Taxes

131K
-0.12%

Stock Price Statistics

The stock price has increased by -64.85% in the last 52 weeks. The beta is 3, so C4 Therapeutics's price volatility has been higher than the market average.

3
-64.85%
2.53
2.43
37.49
1,721,515

Income Statement

In the last 12 months, C4 Therapeutics had revenue of 35.58M and earned -105.32M in profits. Earnings per share was -1.52.

35.58M
35.58M
-119.61M
-105.32M
-103.37M
-105.19M
-1.52
Full Income Statement

Balance Sheet

The company has 55.5M in cash and 65.76M in debt, giving a net cash position of -10.26M.

55.5M
65.76M
-10.26M
-633.7M
296.53M
180.27M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -65.16M and capital expenditures -180K, giving a free cash flow of -65.34M.

-65.16M
-180K
-65.34M
-0.94
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -336.15% and -295.96%.

100%
-336.15%
-295.6%
-295.96%
-290.49%
-336.15%
-183.61%

Dividends & Yields

CCCC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CCCC is $9, which is 311% higher than the current price. The consensus rating is "Buy".

$9
311%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-2.55
3